Corcept Therapeutics Inc (CORT)
54.66
-0.13
(-0.24%)
USD |
NASDAQ |
Nov 15, 09:40
Corcept Therapeutics Free Cash Flow (Quarterly): 72.19M for Sept. 30, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 72.19M |
| June 30, 2024 | 40.77M |
| March 31, 2024 | 23.76M |
| December 31, 2023 | 5.887M |
| September 30, 2023 | 52.87M |
| June 30, 2023 | 42.18M |
| March 31, 2023 | 25.96M |
| December 31, 2022 | 33.36M |
| September 30, 2022 | 33.30M |
| June 30, 2022 | 18.02M |
| March 31, 2022 | 35.24M |
| December 31, 2021 | 49.36M |
| September 30, 2021 | 48.54M |
| June 30, 2021 | 44.22M |
| March 31, 2021 | 25.30M |
| December 31, 2020 | 34.64M |
| September 30, 2020 | 29.73M |
| June 30, 2020 | 53.14M |
| March 31, 2020 | 33.23M |
| December 31, 2019 | 48.32M |
| September 30, 2019 | 38.14M |
| June 30, 2019 | 25.14M |
| March 31, 2019 | 23.42M |
| December 31, 2018 | 21.41M |
| September 30, 2018 | 44.46M |
| Date | Value |
|---|---|
| June 30, 2018 | 15.15M |
| March 31, 2018 | 34.35M |
| December 31, 2017 | 24.85M |
| September 30, 2017 | 10.84M |
| June 30, 2017 | 15.37M |
| March 31, 2017 | 9.451M |
| December 31, 2016 | 4.494M |
| September 30, 2016 | 8.845M |
| June 30, 2016 | 1.583M |
| March 31, 2016 | 3.275M |
| December 31, 2015 | 4.18M |
| September 30, 2015 | 0.883M |
| June 30, 2015 | -0.139M |
| March 31, 2015 | -1.811M |
| December 31, 2014 | -1.403M |
| September 30, 2014 | -5.945M |
| June 30, 2014 | -9.032M |
| March 31, 2014 | -11.17M |
| December 31, 2013 | -7.706M |
| September 30, 2013 | -8.667M |
| June 30, 2013 | -9.24M |
| March 31, 2013 | -11.57M |
| December 31, 2012 | -8.80M |
| September 30, 2012 | -9.281M |
| June 30, 2012 | -7.926M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
5.887M
Minimum
Dec 2023
72.19M
Maximum
Sep 2024
37.50M
Average
34.94M
Median
Free Cash Flow (Quarterly) Benchmarks
| Catalyst Pharmaceuticals Inc | 72.61M |
| ADMA Biologics Inc | 23.93M |
| Akebia Therapeutics Inc | -6.697M |
| Bioventus Inc | 10.25M |
| Alnylam Pharmaceuticals Inc | 39.52M |